Making Strategic Sense of Pharma’s New Race for Competitive Advantage
Fierce Pharma
JULY 11, 2023
The race for competitive advantage for pharma today is about far more than just innovative new molecules.
Patient Acquisition as a Competitive Advantage
Penrod
NOVEMBER 9, 2023
The patient intake experience is a patient’s first impression of your clinic, hospital, or practice. By approaching the intake experience as a competitive advantage, you will attract more patients, decrease patient leakage, and drive more revenue. Let’s seize this moment to redefine healthcare together.
Competition 
52
52 Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Competition in Healthcare is Increasing—Rapidly and Dramatically
Healthcare Success
JUNE 6, 2022
Whether you represent a hospital, health system, or multilocation practice, competing healthcare businesses are developing innovative business models—right now—and they’re targeting your market. What’s more, your highest revenue service lines are likely already facing stiff competition from all angles. .
Competition 112
112 
Sustainable biosimilar competition in Europe: can it be achieved?
European Pharmaceutical Review
OCTOBER 27, 2023
According to The Biosimilar Medicines Group, part of Medicines for Europe, a new report by IQVIA indicates there is a window of opportunity for the EU to foster future-proof biosimilar competition. Failure to attract biosimilar competition The report emphasised that there is a “huge” biosimilar void to 2032, the group shared.
Competition 94
94 
The 7 Ps of Marketing
Healthcare Success
APRIL 8, 2024
As an engineering undergrad, I took a Marketing 101 class on a lark, seeking to better understand the psychology behind consumer behavior and developing products with a competitive edge. On the first day of class, we learned the fundamental concept of the 4 Ps of marketing. What Are the 7 Ps of Marketing? Positioning.
Marketing 112
112 
Patent expiration to drive biosimilars market expansion to 2032
European Pharmaceutical Review
APRIL 11, 2024
Key drivers for the market include patent expirations of several biologic drugs and increasing demand for affordable biologic treatments, the author explained. Over the past few years, the biosimilar market has expanded “rapidly” due to these medicines offering a cost-effective alternative to the reference product.
Marketing 96
96 
Beyond the Pill: Creating Value with Patient-Centric Pharmaceutical Marketing
Pharma Marketing Network
JULY 12, 2023
The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. One way is to use patient-generated content (PGC).
HCPs sound off on pharma marketing
World of DTC Marketing
APRIL 20, 2022
We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. This was especially true with new drugs that have a significant competitive market. They see this as an insurance company coming between them and their patients.
Marketing 218
218 
The debate on DTC marketing is going to heat up again
World of DTC Marketing
JULY 21, 2021
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The voices in Washington DC are once again calling for a moratorium on DTC marketing but lawmakers need to understand what DTC marketing actually does as upped to what people believe it does. DTC ads raise awareness around health conditions.
Marketing 285
285 
ReferralMD Expands Digital Front Door with Conversational AI Patient Registration & Intake
Referral MD
APRIL 23, 2024
The Patient Registration & Intake Solution, powered by conversational AI, reimagines how patients engage with healthcare providers. As part of the Digital Front Door offering, the Patient Registration & Intake Solution improves the patient experience and streamlines the administrative process for healthcare organizations.
Patients 104
104 
Promising schizophrenia drug faces tough competition
European Pharmaceutical Review
NOVEMBER 25, 2022
If approved, paliperidone palmitate extended-release injectable suspension (LY03010) is primed as a favourable option to treat schizophrenia, due to reduced dosage requirement of a once-a-month, yet it risks being hidden in a crowded long-acting injectable (LAI) market, GlobalData warns. percent of the US schizophrenia market in 2031.
Competition 99
99 
How payers can use price transparency as a competitive advantage
Clarify Health
FEBRUARY 20, 2024
This blog explores the transformative potential of price transparency, illustrating how it can transition from a regulatory requirement to a formidable competitive advantage, yielding substantial benefits for health plans and their members.
Competition 52
52 
Competition is on the horizon for costly narcolepsy treatments
pharmaphorum
DECEMBER 14, 2022
When patients experience intense emotion, either positive or negative, they are rendered unconscious. For years, Jazz Pharmaceuticals has dominated the market in treating narcolepsy with cataplexy. For years, Jazz Pharmaceuticals has dominated the market in treating narcolepsy with cataplexy. Competition starts to heat up.
Competition 84
84 
Ethical Considerations in Medical Sales: Maintaining Integrity in a Competitive Industry
Rep-Lite
APRIL 3, 2024
While the goal is ultimately to improve patient outcomes, the competitive nature of the industry can sometimes lead to ethical dilemmas. Ethical considerations in medical sales require constant vigilance and a commitment to putting patient well-being at the forefront of every interaction. Building an Ethical Medical Sales Team?
Ethics 52
52 
Doctor Marketing: How to Integrate Doctors Into Your Marketing Programs
Healthcare Success
NOVEMBER 27, 2023
Moreover, today’s doctor partners have strong opinions about marketing and growing their locations within the larger business. Some of the hospitals and multilocation practices that engage our agency have doctors, executives, investors, and other stakeholders aligned around their brand strategy and marketing plan.
Doctors 117
117 
Multilocation Healthcare Marketing: Minimum Daily Requirements
Healthcare Success
OCTOBER 30, 2023
Do you want to compete in each of your local markets? If so, you need a custom digital marketing strategy and budget for each location. No matter how many locations you have, you must remember that each is its own microcosm and deserves a unique marketing strategy and budget. Not if that marketing builds provable, trackable ROI.
Marketing 118
118 
Sanofi’s FDA Nod in Hemophilia Gives Patients More Convenience, Brings Roche New Competition
MedCity News
FEBRUARY 23, 2023
FDA approval of Sanofi hemophilia A drug Altuviiio provides patients with a therapeutic option that lasts longer than most other products available, including one already marketed by the French pharma giant. Altuviiio also gives Sanofi a way to better compete against blockbuster Roche drug Hemlibra.
Competition 105
105 
Is the launch environment really more competitive now?
pharmaphorum
OCTOBER 7, 2022
It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. The first to market product had ample time to establish and a class market share, at two years, of 100%. Continued competitive intensity. Is this true?
Competition 66
66 
Acquisition deal to back European biosimilars market
European Pharmaceutical Review
NOVEMBER 30, 2023
A report by Act4Biosimilars published earlier this month, highlighted that to support the adoption of these medicines and widen patient access across Europe, measures must be put in place to lower the financial burden of developing these medicines. billion patient treatment days to European patients.”
Marketing 99
99 
Regional inequalities threatening Europe’s biosimilars market
European Pharmaceutical Review
NOVEMBER 16, 2023
The report noted that biosimilar adoption levels vary significantly across Europe because of differences in baseline use of biologics, biosimilar reimbursement, procurement, policies, and education, based on research published in a paper in the Journal of Market Access & Health Policy in 2017.
Marketing 91
91 
Incyte's Opzelura clears skin in children with atopic dermatitis, but safety remains a question
Fierce Pharma
JULY 12, 2023
Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach younger patients with its JAK inhibitor cream Opzelura. Fighting for a place in the competitive atopic dermatitis market, Incyte hopes to reach young patients with its JAK inhibitor cream Opzelura.
Safety 195
195 
How health plans can leverage competitive intelligence data today to drive impact in 2024
Clarify Health
DECEMBER 6, 2023
The strategic use of competitive intelligence data is increasingly becoming a crucial factor for healthcare payers looking to make informed decisions around strategic market expansion and strengthen their market position.
Competition 52
52 
Harnessing the Power of Generational Diversity as a Competitive Advantage
PM360
AUGUST 24, 2023
As professionals with more than a half-century between us working in biopharma and diagnostics marketing and communications from the corporate (Ayaz Malik) and agency (Sandra Stahl) sides, we believe nurturing multigenerational teams is an especially powerful yet underutilized strategy for our industry.
Competition 98
98 
When Does Healthcare Marketing Become Too Niche?
PM360
AUGUST 24, 2023
As healthcare advertisers work to maximize their promotional budgets, an ongoing shift is occurring from broad-based to niche market spending. The competition lies in having the best insights and access to first-party data to secure budgets and then creating opportunities with the reach to maximize these budgets.
Marketing 98
98 
Key metrics or DTC marketers
World of DTC Marketing
AUGUST 11, 2021
You should tell a story on the value of your marketing using metrics that senior managers understand. That’s what most DTC marketers believe because management wants concrete results. However, healthcare marketing is not CPGs or an eCommerce site. INCREASED COMPETITION. Your goal here is to defend your market share.
Marketing 143
143 
9 Healthcare Marketing Trends to Embrace in 2023
Healthcare Success
DECEMBER 6, 2022
In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. Competition from Retail and Telehealth Disruptors Continues to Intensif y. Focus on these key audiences to stay competitive: a.
Healthcare 112
112 
Breaking Through the Clutter in HCP Marketing
LEVO Health
MARCH 4, 2024
Healthcare professionals (HCPs) are currently inundated with information and marketing messages. Therefore, standing out in the crowded HCP marketing space requires strategic innovation and a deep understanding of HCP needs and behaviors. Leveraging Data for Personalized Communication Personalization is key in HCP marketing.
Marketing 52
52 
Accelerating Rare Disease Patient Engagement
Eversana Intouch
AUGUST 10, 2023
The industry challenges faced in marketing in the rare disease space are not new. Limited understanding of the patient or disease. At EVERSANA INTOUCH, our rare expertise and advanced technologies are helping solve some of the most difficult challenges in rare disease marketing. Small populations. Download POV
Patients 82
82 
Should you change your DTC marketing buckets?
World of DTC Marketing
AUGUST 25, 2021
SUMMARY: There is a huge issue that’s challenging DTC marketers: online health misinformation. While we’re still trying to research the changes it has led to for DTC marketers, there are some observable behaviors taking place that we have examined through Google analytics. 3hree: Beware of changing market parameters.
Marketing 154
154 
5 Ways Your Market Access Strategy Can Create a Better-Connected Patient Experience
PM360
SEPTEMBER 28, 2022
Market access stands at the cusp of a golden opportunity to help increase healthcare efficiency, improve outcomes, and transform the patient experience—but only if we’re brave enough to recalibrate our approach. The benefits could be transformative—helping patients navigate the system and accelerating pathways to maximize outcomes.
Patients 105
105 
What We’re Watching for 2024 – Top Trends in Market Access
Eversana Intouch
NOVEMBER 20, 2023
In the rapidly changing landscape of global markets, staying ahead of the curve is crucial for businesses aiming to expand and thrive. As we step into 2024, the realm of market access undergoes dynamic shifts influenced by technological advancements, policy changes, and evolving consumer behaviors.
Marketing 83
83 
How to use predictive analytics in healthcare to better anticipate market shifts
Clarify Health
JANUARY 25, 2024
In the healthcare sector, the strategic use of predictive analytics is crucial for providers aiming to maintain competitiveness. Leveraging data allows them to more accurately anticipate and adapt to market shifts and evolving patient needs.
Healthcare 52
52 
Small molecule API market to value $284.7 billion by 2032
European Pharmaceutical Review
JULY 25, 2023
A report from Market Research Biz has illustrated that the small molecule active pharmaceutical ingredient (API) market is expected value around $284.7 Challenges for growth of the small molecule API market Intellectual property (IP) IP can be a significant barrier to entry into the small molecule API market, the authors noted.
Marketing 79
79 
Genentech’s Chief Marketing Officer Talks Marketing’s New Role and Data-Driven Content
PM360
NOVEMBER 27, 2023
I recently sat down with Erica Taylor, PhD, Vice President and Chief Marketing Officer at Genentech, to talk about the future of biopharma marketing and creating more meaningful content. Pooja Ojala: How do you approach marketing to adapt to today’s healthcare landscape? Marketing is key to adding that layer of storytelling.
Marketing 105
105 
Using Predictive Analytics to Accelerate Time to Market in Healthcare
Clarify Health
NOVEMBER 15, 2023
Health plans and care delivery organizations face steep competition for customers and patients, so it’s essential to move swiftly to gain customer loyalty and market share when launching a new health plan or service line. But, as the saying goes, only fools rush in. Risk stratification. Predicting customer churn.
Healthcare 52
52 
Integrating Digital Marketing in Pharmaceutical Industry: Unlocking New Opportunities for Patient Outreach and Engagement
Pharma Marketing Network
MAY 3, 2023
The pharmaceutical industry has undergone significant changes in recent years, with digital marketing playing an increasingly important role in the way companies communicate with customers and stakeholders. Another key advantage of digital marketing is the ability to measure and analyze the effectiveness of campaigns in real-time.
Marketing 52
52 
Current and future players in the lupus market
Pharmaceutical Technology
JANUARY 23, 2023
The term LN refers to a major predictor of poor prognosis in SLE patients, with inflammation of the kidney that encompasses diverse patterns of renal disease, including glomerular and vascular pathology. In previous years, Benlysta has managed to grow the lupus market in terms of value, having generated approximately $492.9m
Marketing 111
111 
Four Vital Optimizations Required For Digital Marketing Success
Healthcare Success
JANUARY 3, 2023
I’ve noticed that most people tend to focus on only one of four variables when optimizing their digital marketing results. search engine marketing, SEM, pay-per-click, or PPC). All too often, we see marketers and clients focusing solely on one piece of the puzzle: the "in the machine" campaign management. Competition.
Marketing 108
108 
Clarify Health and Ideon Partner to Build Stronger, More Competitive Health Plan Networks
Clarify Health
JUNE 29, 2023
Ideon will power Clarify Networks’ competitive intelligence software module with national insurance network data across commercial, Affordable Care Act (ACA), and Medicare Advantage (MA) markets to empower health plans to gain valuable insights into their competitors’ networks. Levin, co-founder and CEO of Ideon.
Networking 52
52 
The Role of ChatGPT in Enhancing Pharma Marketing Efficiency and Effectiveness
PM360
MAY 25, 2023
ChatGPT is poised to revolutionize the pharmaceutical industry by providing innovative communication and marketing strategies. Gone are the days of vague marketing messages such as “Ask your doctor if this is right for you.” With AI-powered chatbots and services, patients can access the information they need more efficiently.
Marketing 98
98 
Medical Device Marketing: Targeting the Right Patients at the Right Time
LEVO Health
OCTOBER 26, 2022
The medical device market is more saturated than you might think. With seemingly countless treatment options on the table, how can your device cut through the clutter and get in front of the right patients at just the right time? You need a marketing strategy that sets your medical device apart from the competition.
Medical 52
52 
6 Healthcare Marketing Strategies to Skyrocket Your Growth in 2023
LEVO Health
DECEMBER 20, 2022
Healthcare is a rapidly changing industry, and if you want to stay ahead of the curve, you’ll need to adopt some cutting-edge marketing strategies. As 2023 approaches, there are several strategies you can adopt to improve your healthcare marketing efforts and grow your practice. 6 Medical Marketing Strategies to Adopt in 2023.
Healthcare 98
98 
Multilocation Marketing in Healthcare: The Biggest Challenges
Healthcare Success
MAY 1, 2023
Building a multilocation healthcare business expands your reach, patient base, and profit margin. But, these benefits come with several unique marketing challenges. They also come with remarkable marketing opportunities. You’re also delivering confusing and disjointed messages to doctors, staff, patients, and referring doctors.
Marketing 65
65 
Oncology is Increasingly Competitive – Here’s How to Stand Out
Eversana Intouch
MARCH 31, 2023
It’s an exciting era in oncology: many new drugs with increasing benefits and more tolerable profiles are being developed and released, and that means that nearly all tumor type spaces are becoming more competitive. There’s much more to be done, but it’s generally great news for patients, bringing them hope and choice they didn’t have before.
Competition 52
52 
Let's personalize your content